Daiki Nakagomi

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

Shunsuke Furuta, Daiki Nakagomi, Y Kobayashi et al. · JAMA · 2021 · 217 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Ultrasound Can Improve the Accuracy of the 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis to Predict the Requirement for Methotrexate Treatment

Daiki Nakagomi, Kei Ikeda, Ayako Okubo et al. · Arthritis & Rheumatism · 2013 · 122 citations

Medicine, Clinical Sciences, Internal Medicine +13

Prediction of Relapse After Discontinuation of Biologic Agents by Ultrasonographic Assessment in Patients With Rheumatoid Arthritis in Clinical Remission: High Predictive Values of Total Gray‐Scale and Power Doppler Scores That Represent Residual Synovial Inflammation Before Discontinuation

Taro Iwamoto, Kei Ikeda, Junichi Hosokawa et al. · Arthritis Care & Research · 2014 · 117 citations

Medicine, Radiology, Inflammation +16

Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype

Aladdin J Mohammad, Kristian H. Mortensen, Judith Babar et al. · The Journal of Rheumatology · 2017 · 116 citations

Medicine, Pathology, Radiology +13

[18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis

Shigeru Tanaka, Kei Ikeda, Katsuhiro Uchiyama et al. · Lara D. Veeken · 2013 · 98 citations · Full text

Medicine, Immunology, Immunopathology +15